Kereos’ collaborators have published dozens of research papers on the discovery of Kereos’ targeted therapy and molecular imaging candidates.
A few of note:
Cancer MRI
Winter PM, Caruthers SD, Kassner A, Harris TD, Chinen LK, Allen JS, Zhang H, Robertson DJ, Wickline SA, Lanza GM: Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel avb3-targeted nanoparticle and 1.5 Tesla MRI. Cancer Research 2003; 63:5838-43.
CVD MRI
Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang H, Williams TA, Allen JS, Robertson JD, Lanza GM, Wickline SA: Molecular imaging of angiogenesis in early-stage atherosclerosis with avb3-integrin-targeted nanoparticles. Circulation 2003; 108:2270-4.
CVD MRI
Flacke S, Fischer S, Scott MJ, Fuhrhop RJ, Allen JS, McLean M, Winter P, Sicard GA, Gaffney PJ, Wickline SA, Lanza GM: Novel MRI contrast agent for molecular imaging of fibrin: Implications for detecting vulnerable plaques. Circulation 2001; 104: 1280-1285.
|